A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. II. 5-Hydroxytryptamine tolerance before and after Nialamide.
D003863:Depression / Q000628:therapy*; D003866:Depressive Disorder; D004361:Drug Tolerance; D007108:Immune Tolerance; D007490:Iproniazid / Q000031:analogs & derivatives; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D009526:Nialamide; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D012701:Serotonin / Q000494:pharmacology*
D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D007490:Iproniazid; D010088:Oxidoreductases; D008995:Monoamine Oxidase; D009526:Nialamide
DEPRESSION/therapy; IPRONIAZID/related compounds; OXIDASES/antagonists; SEROTONIN/pharmacology